NEWS

Clinical Trial Aims to Address Vaginal Complaints After Breast Cancer Diagnosis

April 13, 2026 – The Alliance for Clinical Trials in Oncology is now enrolling patients into a clinical trial aimed at helping women recover from the vaginal side effects of breast cancer treatment. Supported in part by a grant from the National Cancer Institute, the REVITALIZE study (Alliance A221801) will test if a laser therapy helps reduce vaginal dryness caused by breast cancer treatment, a painful


Antidepressant Unable to Prevent Chemotherapy-Associated Nerve Damage

April 8, 2026 - A randomized trial conducted by the Alliance for Clinical Trials in Oncology with support from the National Cancer Institute has found that duloxetine, a medication commonly used to treat chronic pain and psychiatric conditions, does not prevent nerve damage caused by chemotherapy in patients with colorectal cancer. The primary analysis of Alliance A221805 was published in JCO Oncolog


Alliance Marks Adolescent and Young Adult Cancer Awareness Week

April 7, 2026 - Each year, about 85,000 adolescents and young adults (AYA) between the ages of 15 and 39 are diagnosed with cancer in the United States. According to the National Cancer Institute, this represents about 4% of all new cancer diagnoses.

Depending on age and specific diagnosis, many AYA people with cancer may be treated at either a pediatric cancer center or an adult cancer center. However, often these p


Older News